The Bioeconomics of Covid-19
By Judith Levine,
n+1
| 11. 13. 2020
How, exactly, do we value a human life?
Back of the 50 centime emergency note issued in 1916 by the Merksplas Local Board of the National Assistance and Food Committee © Museum of the National Bank of Belgium
Biopower and necropolitics
IN DISCIPLINE & PUNISH Michel Foucault describes the measures taken, as per magisterial edict, in a plague-ridden French city sometime in the late seventeenth century. On the first day of quarantine, everyone is ordered to stay indoors; the doors are locked from the outside. Sentinels are posted at the city gates. Armed guards patrol the town hall.
Each street is placed under the surveillance of a syndic, who visits every house every day, speaking through a window. “Everything that may be observed during the course of the visits—deaths, illnesses, complaints, irregularities—is noted down and transmitted” to the city authorities. A resident who goes out without permission or a syndic who leaves the street may be sent to the gallows. Public health and social control go hand in hand.
The authorities recognize an obligation to the people inside the houses, who receive a kind of care, albeit compulsory: interrogations...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...